SCM
IBIO icon

Silverarc Capital Management’s iBio IBIO Stock Holding History

Silverarc Capital Management’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.16M Buy
3,520,490
+3,294,490
+1,458% +$5.89M 0.64% 47
2026
Q1 		$429K Buy
226,000
+120,000
+113% +$278K 0.04% 70
2025
Q4 		$205K Buy
+106,000
New +$145K 0.03% 67

Other funds holding IBIO

AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Silverarc Capital Management's IBIO Position: Q2 2026 in Review

Silverarc Capital Management increased its iBio (IBIO) stake by 1,458% in Q2 2026, buying an estimated $5.89M and bringing the position to 3,520,490 shares worth $6.16M. The position accounts for 0.64% of the portfolio, ranked #47.

Silverarc Capital Management first reported a position in IBIO in Q4 2025 and has held it in 3 quarters since. 55 funds tracked by Wall St. Rank hold IBIO as of Q2 2026.

  • Silverarc Capital Management held 3,520,490 shares of iBio worth $6.16M as of Q2 2026.
  • Silverarc Capital Management bought 3,294,490 iBio shares in Q2 2026, an estimated $5.89M.
  • iBio made up 0.64% of Silverarc Capital Management's portfolio in Q2 2026, its #47 holding.
  • Silverarc Capital Management first reported a position in iBio in Q4 2025 and has held it in 3 quarters since.
  • 55 funds tracked by Wall St. Rank held iBio as of Q2 2026.

Based on Silverarc Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.